secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001193125-25-008461
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology adopts 2025 Inducement Plan, reserves 1.5M shares for new-hire equity awards
--------------------------------------------------------------------------------

- Board approved Inducement Plan on Jan 16, 2025; effective immediately.
- 1,500,000 shares of common stock reserved for issuance under the plan.
- Awards are limited to new employees as a material inducement to join the company, per Nasdaq Listing Rule 5635(c)(4).
- Plan terms are substantially similar to ALX's existing 2020 Equity Incentive Plan.
- No shareholder approval was required for adoption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/0001193125-25-008461-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/d909443d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-008461

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer